Company Tonix Pharmaceuticals Holding Corp Nasdaq
Equities
US8902604094
Pharmaceuticals
Business Summary
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Therapeutics
100.0
%
| 0 | nan % | 8 | 100.0 % | - |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 0 | nan % | 8 | 100.0 % | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 84,490,862 | 84,485,661 ( 99.99 %) | 0 | 99.99 % |
Company contact information
Tonix Pharmaceuticals Holding Corp.
26 Main Street Suite 101
07928, Chatham
+862 799 8599
http://www.tonixpharma.comSector
1st Jan change | Capi. | |
---|---|---|
-3.45% | 87.17B | |
+1.97% | 40.1B | |
+57.73% | 25.12B | |
-14.82% | 15.59B | |
-8.82% | 12B | |
-16.29% | 11.8B | |
-41.58% | 11.8B | |
+6.89% | 8.81B | |
-10.53% | 8.24B |